BrightPath Biotherapeutics
4594.TTSE GROWTHPharmaceutical
Filed as BrightPath Biotherapeutics Co., Ltd (2022-06–2026-06)
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 4
| Phillip Securities Japan, Ltd. | 4.88% |
| Evo Fund | 4.62% |
| Macquarie Bank Limited | 1.84% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| Evo Fund2024-07-12 · amended | 28.37% | -1.41pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 29.78% | -2.16pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | new |
| Evo Fund2024-07-12 · amended | 31.94% | new |
| Macquarie Bank Limited2024-04-03 · amended | 10.92% | -1.09pp |
| Macquarie Bank Limited2024-03-15 · amended | 12.01% | -1.56pp |
| Macquarie Bank Limited2024-03-08 · amended | 13.57% | -1.09pp |
| Macquarie Bank Limited2024-02-29 · amended | 14.66% | -0.95pp |
| Macquarie Bank Limited2024-02-16 · amended | 15.61% | -1.10pp |
| Macquarie Bank Limited2024-02-01 · amended | 16.71% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.